The importance of research in cancer nursing
The debate at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate, UK, focused on highlighting the importance of different areas of cancer nursing, including research. In this ...
Author: VJOncology
Added: 12/12/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 12, 2017 Category: Cancer & Oncology Source Type: podcasts
Curbing cancer patients expectations of immunotherapy
Immunotherapy is a growing treatment area for cancer, with a lot of hype in the mainstream media. In this interview, recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017, held in...
Author: VJOncology
Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts
Exportin (XPO1) inhibitors for the treatment of AML
Inhibitors of exportin (XPO1), a nuclear export chaperone, are currently in early clinical trials for acute myeloid leukemia (AML). Speaking from the International Conference on Acute Myeloid Leukaemi...
Author: VJHemOnc
Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts
Novel targets for AML
"There are currently a number of ongoing clinical trials for acute myeloid leukemia (AML) that are targeting nuclear exporters. In this video, recorded at the International Conference on Acute My...
Author: VJHemOnc
Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts
The spliceosome mutations that can cause hematological malignancies
There are four commonly mutated spliceosome proteins in hematological malignancies. In this interesting interview, recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, ...
Author: VJHemOnc
Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts
Working with smaller research companies
Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH), Stphane de Botton, MD, PhD of the Gustave Roussy Institute, ...
Author: VJHemOnc
Added: 12/06/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 6, 2017 Category: Cancer & Oncology Source Type: podcasts
Transferring lessons learnt from treating ALL to AML
Reflecting upon past research is key to the development of new treatments. In this interview at the International Conference of Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School o...
Author: VJHemOnc
Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts
The development of novel treatment modalities: regulations and expectations
Novel technologies have the potential to allow us to treat more ailments, but often come at the price of new toxicities. Speaking from the International Conference of Acute Myeloid Leukaemia 2017, Est...
Author: VJHemOnc
Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts
Game-changing treatments for leukemia
This is an exciting time for leukemia treatment, with multiple new therapies being approved and various agents on the horizon. At the International Conference of Acute Myeloid Leukaemia 2017 in Estori...
Author: VJHemOnc
Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts
Neomorphic mutations driving hematological cancers
It is known that spliceosome gene mutations can drive hematological cancers, but there may also be neomorphic mutations at play. In this video, recorded at the International Conference on Acute Myeloi...
Author: VJHemOnc
Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts
Venetoclax for elderly AML patients
The BCL2 inhibitor venetoclax has shown remarkable response rates in elderly acute myeloid leukemia (AML) patients when used in combination regimens. Speaking at the International Conference on Acute ...
Author: VJHemOnc
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
& quot;AML immunotherapy: pre-clinical data to look forward to at ASH 2017 & quot;
It is still early days for immunotherapeutic strategies. Speaking from the International Conference on Acute Myeloid Leukemia 2017, Estoril, Portugal by the European School of Hematology (ESH), Marion...
Author: VJHemOnc
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
Adapting acute oncology services to immunotherapy
An acute oncology service works to manage the unexpected care needs of patients with cancer. In this interview, recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate,...
Author: VJOncology
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
National Lung Cancer Forum for Nurses (NLCFN) update
The National Lung Cancer Forum for Nurses (NLCFN) Annual Conference 2017 covered a wide range of areas, including smoking cessation, the patient care pathway and the national lung cancer audit. In thi...
Author: VJOncology
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
The value of UKONS
Conferences can be a fantastic opportunity to network within a certain profession, and get an idea of the challenges that are facing a profession as a whole. In this interview, Daniel Kelly, PhD, from...
Author: VJOncology
Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts
